Contrasting roles for CXCR2 during experimental colitis

Experimental and Molecular Pathology

Volumn 76, Issue 1, 2004, Pages 1-8

  Ajuebor, Maureen N ^a   Zagorski, John ^b   Kunkel, Steven L ^c   Strieter, Robert M ^d   Hogaboam, Cory M ^c  

^a UNIVERSITY OF CALGARY   (Canada)

^b David Axelrod Institute   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Colitis; CXCL1 KC; CXCR2; Inflammation; Neutrophils; TNBS

Indexed keywords

CHEMOKINE RECEPTOR CXCR2; NEUTRALIZING ANTIBODY; TRINITROBENZENESULFONIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; CELLULAR DISTRIBUTION; COLITIS; CONTROLLED STUDY; DISEASE MODEL; INFLAMMATION; MALE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; SERODIAGNOSIS;

EID: 0346040262     PISSN: 00144800     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexmp.2003.08.004     Document Type: Article

References (23)

1. Ajuebor M.N., Swain M.G. Role of chemokines and chemokine receptors in the gastrointestinal tract. Immunology. 105:2002;137.
2. Ajuebor M.N., Singh A., Wallace J.L. Cyclooxygenase-2-derived prostaglandin D(2) is an early anti-inflammatory signal in experimental colitis. Am. J. Physiol., Gastrointest. Liver Physiol. 279:2000;G238.
3. Ajuebor M.N., Hogaboam C.M., Kunkel S.L., Proudfoot A.E., Wallace J.L. The chemokine RANTES is a crucial mediator of the progression from acute to chronic colitis in the rat. J. Immunol. 166:2001;552.
4. Anezaki K., Asakura H., Honma T., Ishizuka K., Funakoshi K., Tsukada Y., Narisawa R. Correlations between interleukin-8, and myeloperoxidase or luminol-dependent chemiluminescence in inflamed mucosa of ulcerative colitis. Intern. Med. 37:1998;253.
5. Belperio J.A., Keane M.P., Burdick M.D., Londhe V., Xue Y.Y., Li K., Phillips R.J., Strieter R.M. Critical role for CXCR2 and CXCR2 ligands during the pathogenesis of ventilator-induced lung injury. J. Clin. Invest. 110:2002;1703.
6. Bhatia M., Brady M., Zagorski J., Christmas S.E., Campbell F., Neoptolemos J.P., Slavin J. Treatment with neutralising antibody against cytokine induced neutrophil chemoattractant (CINC) protects rats against acute pancreatitis associated lung injury. Gut. 47:2000;838.
7. Boisvert W.A., Santiago R., Curtiss L.K., Terkeltaub R.A. A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice. J. Clin. Invest. 101:1998;353.
8. Buell M.G., Berin M.C. Neutrophil-independence of the initiation of colonic injury. Comparison of results from three models of experimental colitis in the rat. Dig. Dis. Sci. 39:1994;2575.
9. Campbell S.J., Hughes P.M., Iredale J.P., Wilcockson D.C., Waters S., Docagne F., Perry V.H., Anthony D.C. CINC-1 is an acute-phase protein induced by focal brain injury causing leukocyte mobilization and liver injury. FASEB J. 17:2003;1168.
10. Daig R., Andus T., Aschenbrenner E., Falk W., Scholmerich J., Gross V. Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease. Gut. 38:1996;216.
11. Galvez J., Garrido M., Merlos M., Torres M.I., Zarzuelo A. Intestinal anti-inflammatory activity of UR-12746, a novel 5-ASA conjugate, on acute and chronic experimental colitis in the rat. Br. J. Pharmacol. 130:2000;1949.
12. Izzo R.S., Witkon K., Chen A.I., Hadjiyane C., Weinstein M.I., Pellecchia C. Interleukin-8 and neutrophil markers in colonic mucosa from patients with ulcerative colitis. Am. J. Gastroenterol. 87:1992;1447.
13. Keshavarzian A., Fusunyan R.D., Jacyno M., Winship D., MacDermott R.P., Sanderson I.R. Increased interleukin-8 (IL-8) in rectal dialysate from patients with ulcerative colitis: evidence for a biological role for IL-8 in inflammation of the colon. Am. J. Gastroenterol. 94:1999;704.
14. Luster A.D. Chemokines - chemotactic cytokines that mediate inflammation. N. Engl. J. Med. 338:1998;436.
15. Mazzucchelli L., Hauser C., Zgraggen K., Wagner H., Hess M., Laissue J.A., Mueller C. Expression of interleukin-8 gene in inflammatory bowel disease is related to the histological grade of active inflammation. Am. J. Pathol. 144:1994;997.
16. McCafferty D.M., Rioux K.J., Wallace J.L. Granulocyte infiltration in experimental colitis in the rat is interleukin-1 dependent and leukotriene independent. Eicosanoids. 5:1992;121.
17. McCafferty D.M., Sharkey K.A., Wallace J.L. Beneficial effects of local or systemic lidocaine in experimental colitis. Am. J. Physiol. 266:1994;G560.
18. Podolin P.L., Bolognese B.J., Foley J.J., Schmidt D.B., Buckley P.T., Widdowson K.L., Jin Q., White J.R., Lee J.M., Goodman R.B., Hagen T.R., Kajikawa O., Marshall L.A., Hay D.W., Sarau H.M. A potent and selective nonpeptide antagonist of CXCR2 inhibits acute and chronic models of arthritis in the rabbit. J. Immunol. 169:2002;6435.
19. Schuh J.M., Blease K., Hogaboam C.M. CXCR2 is necessary for the development and persistence of chronic fungal asthma in mice. J. Immunol. 168:2002;1447.
20. Schuh J.M., Blease K., Hogaboam C.M. The role of CC chemokine receptor 5 (CCR5) and RANTES/CCL5 during chronic fungal asthma in mice. FASEB J. 16:2002;228.
21. Terkeltaub R., Baird S., Sears P., Santiago R., Boisvert W. The murine homolog of the interleukin-8 receptor CXCR-2 is essential for the occurrence of neutrophilic inflammation in the air pouch model of acute urate crystal-induced gouty synovitis. Arthritis Rheum. 41:1998;900.
22. Tozawa K., Hanai H., Sugimoto K., Baba S., Sugimura H., Aoshi T., Uchijima M., Nagata T., Koide Y. Evidence for the critical role of interleukin-12 but not interferon-gamma in the pathogenesis of experimental colitis in mice. J. Gastroenterol. Hepatol. 18:2003;578.
23. Wallace J.L., McKnight W., Asfaha S., Liu D.Y. Reduction of acute and reactivated colitis in rats by an inhibitor of neutrophil activation. Am. J. Physiol. 274:1998;G802.